FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:212 January 18, 2007 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Interview Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The rapidly increasing global burdens of cardiovascular disease and diabetes call for interventions that have a population-wide effect, as well as interventions that identify and protect individual patients who have a high risk of major adverse events. Such actions are especially needed in low-income and middle-income countries, which can ill afford the huge losses in human and financial resources that will result from unchecked development of clinical disease.¹

Many drugs have been found to be highly effective in the primary or secondary prevention of cardiovascular disease. These include aspirin, angiotensin-converting–enzyme (ACE) inhibitors, statins, beta-blockers, and calcium-channel blockers. Despite their potential . . . [Full Text of this Article]

Source Information

Dr. Reddy is the president of the Public Health Foundation of India and a professor of cardiology at the All India Institute of Medical Sciences, New Delhi.

An interview with Dr. Reddy can be heard at www.nejm.org.

This article has been cited by other articles:

• Wald, D. S, Morton, G., Walker, K., Iosson, N., Curzen, N. P (2007). Long-Term Continuation on Cardiovascular Drug Treatment in Patients with Coronary Heart Disease. The Annals of Pharmacotherapy 41: 1644-1647 [Abstract] [Full Text]  
• Anderson, G. F., Frogner, B. K., Reinhardt, U. E. (2007). Health Spending In OECD Countries In 2004: An Update. Health Aff (Millwood) 26: 1481-1489 [Abstract] [Full Text]  
• Matfin, G. (2007). Aspects of drug development and clinical trials -- Part 2. British Journal of Diabetes & Vascular Disease 7: 149-150  
• Matfin, G. (2007). Review: Challenges in developing therapies for the metabolic syndrome. British Journal of Diabetes & Vascular Disease 7: 152-156 [Abstract]